Infusion of herbal plant extracts for insomnia and anxiety causes a dose-dependent increase of NO and has a protective effect on the renal cellular stress caused by hypoxia and reoxygenation

  1. J.M. Maixent1,2,4*,
  2. M. Fares2,
  3. C. François2,3

Authors Affiliation(s)

  • 1Laboratoire PROTEE, EA – Université de Toulon, Toulon-La Garde 83957, FRANCE
  • 2Inserm U927, Ischémie-reperfusion en transplantation rénale, Poitiers, FRANCE
  • 3Laboratoire Velay, Puy en Velay, FRANCE
  • 4UF Biosanté, Faculté des Sciences Fondamentales et Appliquées, 40 rue du recteur Pineau, Poitiers Cedex 86022, Université de Poitiers, FRANCE

Can J Biotech, Volume 2, Issue 3, Pages 116-123, DOI: https://doi.org/10.24870/cjb.2018-000123

Received: Jul 18, 2018; Revised: Oct 1, 2018; Accepted: Oct 10, 2018

Abstract

Background: Herbal plant extracts are a more common alternative to conventional medicine to treat sleep disorders and intermittent hypoxia. Notably, obstructive sleep apnea causes injuries similar to those observed in models of ischemia-reperfusion including the decrease of nitric oxide (NO) availability. Kidney transplantation in end-stage renal disease reverses the sleep apnea. The underlying mechanism linking hypoxia, sleep apnea, and renal protection remains to be defined at the cellular level.
Objective: The aim of this study was to demonstrate the safety and efficacy of herbal plant infusions with a potential for donating NO, to attenuation of damage induced during a hypoxia/reperfusion sequence, on kidney epithelial cells LLC-PK1.
Materials and Methods: Cell death (Lactate Dehydrogenase release assay) and a viability test (MTS assay) after 24 h of incubation with different concentrations of plant infusion were assessed using the LLC-PK1 cell line. Then, measurement of the breakdown product of NO (the NaNO2) and LDH assay were carried out after 24 h of hypoxia, followed by 4 h or 24 h of reperfusion.
Results: The effect of different dilutions of herbal plant infusion on the LLC-PK1 cell viability, after 24 h of incubation, was maximal at a 30% dilution compared to control. After 24 h of hypoxia, there was an increase of NaNO2 and thus of NO, and a concentration-dependent decrease of cell death. Similar results were observed after hypoxia followed by 4 h of reperfusion. These effects were always maximal at 50% dilution of plants infusion.
Conclusion: Safe infusion of plant extracts causes a dose-dependent increase of NO and has a protective effect against the cellular stress caused by hypoxia and reoxygenation. Since it has been demonstrated that there is a NO-dependent mechanism allowing the reduction of injuries induced by ischemia/reoxygenation process, such a mechanism could be responsible for our observations.

References

  1. Williamson, E.M. (2001) Synergy and other interactions in phytomedicines. Phytomedicine 8: 401-409. Crossref
  2. Saeed, S.A., Bloch, R.M. and Antonacci, D.J. (2007) Herbal and dietary supplements for treatment of anxiety disorders. Am Fam Physician 76: 549-556.
  3. Kinrys, G., Coleman, E. and Rothstein, E. (2009) Natural remedies for anxiety disorders: potential use and clinical applications. Depress Anxiety 26: 259-265. Crossref
  4. Sarris, J., Kavanagh, D.J. and Byrne, G. (2010) Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. J Psychiatr Res 44: 32-41. Crossref
  5. Sharma A.,Cardoso-Taketa, A., Garcia, G.and Villarreal,M.L. (2012) A systematic updated review of scientifically tested selected plants used for anxiety disorders. Botanics: Targets and Therapy 2012: 21-39. Crossref
  6. Atkeson, A. and Jelic, S. (2008) Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vasc Health Risk Manag 4: 1327-1335. Crossref
  7. Guix, F.X., Uribesalgo, I., Coma, M. and Munoz, F.J. (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76: 126-152. Crossref
  8. Prabhakar, N.R. (2002) Sleep apneas:an oxidative stress? Am J Respir Crit Care Med 165: 859-860. Crossref
  9. Yang, X.H., Zhang, B.L., Gu, Y.H., Zhan, X.L., Guo, L.L. and Jin, H.M. (2018) Association of sleep disorders, chronic pain, and fatigue with survival in patients with chronic kidney disease: a meta-analysis of clinical trials. Sleep Med 51: 59-65. Crossref
  10. Perl, J., Unruh, M.L. and Chan, C.T. (2006) Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis’? Kidney Int 70: 1687-1693. Crossref
  11. Johnston, J.G. and Pollock, D.M. (2018) Circadian regulation of renal function. Free Radic Biol Med 119: 93-107. Crossref
  12. Rivier, C.(2001) Role of gaseous neurotransmitters in the hypothalamic-pituitary-adrenal axis. Ann N Y Acad Sci 933:254-264. Crossref
  13. Datta, S., Patterson, E.H. and Siwek, D.F. (1997) Endogenous and exogenous nitric oxide in the pedunculopontine tegmentum induces sleep. Synapse 27: 69-78. Crossref
  14. Hars, B. (1999) Endogenous nitric oxide in the rat pons promotes sleep. Brain Res 816: 209-219. Crossref
  15. Cavas, M. and Navarro, J.F. (2006) Effects of selective neuronal nitric oxide synthase inhibition on sleep and wakefulness in the rat. Prog Neuro-Psychopharmacol Biol Psychiatry 30: 56-67. Crossref
  16. Lurie, A. (2011) Endothelial dysfunction in adults with obstructive sleep apnea. Adv Cardiol 46: 139-170. Crossref
  17. François, C., Fares, M., Baiocchi, C. and Maixent, J.M. (2015) Safety of Desmodium adscendens extract on hepatocyte and renal cells. Protective effect against oxidative stress. J Intercult Ethnopharmacol 4: 1-5. Crossref
  18. Bartels-Stringer, M., Verpalen, J.T., Wetzels, J.F., Russel, F.G. and Kramers, C. (2007) Iron chelation or anti-oxidants prevent renal cell damage in the rewarming phase after normoxic, but not hypoxic cold incubation. Cryobiology 54: 258-264. Crossref
  19. Fares, M., Armand, M., François, C. and Maixent, J.M. (2012) ω6/ω3 polyunsaturated fatty acid supplementations in renal cell model lead to a particular regulation through lipidome for preserved ω6/ω3 ratios. Cell Mol Biol (Noisy-le-grand) 58: OL1715-OL1719. Crossref
  20. Salahudeen, A.K., Huang, H., Joshi, M., Moore, N.A. and Jenkins, J.K. (2003) Involvement of themitochondrialpathway in cold storage and rewarming-associated apoptosis of human renal proximal tubular cells. Am J Transplant 3: 273-280. Crossref
  21. Koyama, I., Bulkley, G.B., Williams, G.M. and Im, M.J. (1985) The role of oxygen free radicals in mediating the reperfusion injury of cold-preserved ischemic kidneys. Transplantation 40: 590-595.
  22. Paller, M.S. (1992) Free radical-mediated postischemic injury in renal transplantation. Ren Fail 14: 257-260. Crossref
  23. Sakon, M., Ariyoshi, H., Umeshita, K. and Monden, M. (2002) Ischemia-reperfusion injury of the liver with special reference to calcium-dependent mechanisms. Surg Today 32: 1-12. Crossref
  24. Quintana, A., Rodriguez, J.V., Scandizzi, A. and Guibert, E.E.(2001) Effect of S-nitrosoglutathione (GSNO) added to the University of Wisconsin solution (UW): I) Morphological alteration during cold preservation/reperfusion of rat liver. Int J Surg Investig 2: 401-411.
  25. Quintana, A.B., Rodriguez, J.V., Scandizzi, A.L. and Guibert, E.E. (2003) The benefit of adding sodium nitroprusside (NPNa) or S-nitrosoglutathion (GSNO) to the University of Wisconsin solution (UW) to prevent morphological alterations during cold preservation/reperfusion of rat livers. Ann Hepatol 2: 84- 91.
  26. Nakano, A., Liu, G.S., Heusch, G., Downey, J.M. and Cohen, M.V. (2000) Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 32: 1159- 1167. Crossref
  27. Valdivielso, J.M., Crespo, C., Alonso, J.R., Martinez- Salgado, C., Eleno, N., Arevalo, M., Perez-Barriocanal, F. and Lopez-Novoa, J.M. (2001) Renal ischemia in the rat stimulates glomerular nitric oxide synthesis. Am J Physiol Regul Integr Comp Physiol 280: R771-R779. Crossref
  28. Liang, M. and Knox, F.G. (2000) Production and functional roles of nitric oxide in the proximal tubule. Am J Physiol Regul Integr Comp Physiol 278: R1117-R1124. Crossref
  29. Yu, L., Gengaro, P.E., Niederberger, M., Burke, T.J. and Schrier, R.W. (1994) Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci U S A 91: 1691-1695. Crossref
  30. Noiri, E., Peresleni, T., Miller, F. and Goligorsky, M.S. (1996) In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest 97:2377-2383. Crossref
  31. Chiao,H., Kohda, Y., McLeroy, P., Craig, L., Housini, I. and Star, R.A. (1997) Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99: 1165-1172. Crossref
  32. Garcia-Criado, F.J., Eleno, N., Santos-Benito, F., Valdunciel, J.J., Reverte, M., Lozano-Sanchez, F.S., Ludena, M.D., Gomez-Alonso, A. andLopez-Novoa, J.M. (1998) Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation 66: 982-990. Crossref
  33. Katori, M., Tamaki, T., Takahashi, T., Tanaka, M., Kawamura, A. and Kakita, A. (2000) Prior induction of heat shock proteins by a nitric oxide donor attenuates cardiac ischemia/reperfusion injury in the rat. Transplantation 69: 2530-2537.
  34. Beckman, J.S. and Crow, J.P. (1993) Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 21: 330-334. Crossref
  35. Southan, G.J. and Szabo, C. (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51: 383-394. Crossref
  36. Pierre, S.V., Lesnik, P., Moreau, M., Bonello, L., Droy- Lefaix, M.T., Sennoune, S., Duran, M.J., Pressley, T.A., Sampol, J., Chapman, J. and Maixent, J.M. (2008) The standardized Ginkgo Biloba extract EGB-761 protects vascular endothelium exposed to oxidized low density lipoproteins. Cell Mol Biol 54: OL1032-OL1042.
  37. Braud, L., Peyre, L., deSousa, G., Armand, M., Rahmani, R. and Maixent, J.M. (2015) Effect of brewing duration on the antioxidant and hepatoprotective abilities of tea phenolic and alkaloid compounds in a t-BHP oxidative stress-induced rat hepatocyte model. Molecules 20: 14985-15002. Crossref
  38. Braud, L., Battault, S., Nascimento, A., Gaillard, S., de Sousa, G., Rahmani, R., Riva, C., Armand, M.,Maixent,J.M. and Reboul, C. (2017) Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFDL obese rat model. J Nutr Biochem 40: 95-104. Crossref